Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetails
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
It is a patently false contention to tell religious leaders to mind things moral and spiritual and leave temporal or...
Read moreDetails
The defeat of the Bill linked to women’s reservation in the Lok Sabha on 17 April is not merely a...
Read moreDetails
By Aakar Patel What explains our inability or, if we are to be charitable, our reticence, to influence the world...
Read moreDetails
By Dilip Cherian If you thought turf wars in Delhi were messy, Tamil Nadu has just offered a tighter, sharper...
Read moreDetails
